The Selective Syk Inhibitor P505-15 (PRT062607) Inhibits B Cell Signaling and Function In Vitro and In Vivo and Augments the Activity of Fludarabine in Chronic Lymphocytic LeukemiaStephen E. Spurgeon, Marc Loriaux|Journal of Pharmacology and Experimental Therapeutics|2012Cited by 53